Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia

PHASE2UnknownINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 2006

Conditions
Kidney DiseasesRenal Insufficiency
Interventions
DRUG

ILY101

Trial Locations (18)

54911

Clinical Study Site, Appleton

Unknown

Clinical Study Site, Mobile

Clinical Study Site, Mountain View

Clinical Study Site, Riverside

Clinical Study Site, San Diego

Clinical Study Site, Thornton

Clinical Study Site, Ocala

Clinical Study Site, Palm Beach Gardens

Clinical Study Site, Pembroke Pines

Clinical Study Site, Des Moines

Clinical Study Site, Baton Rouge

Clinical Study Site, Rochester

Clinical Study Site, Allentown

Clinical Study Site, Houston

Clinical Study Site, San Antonio

Clinical Study Site, Provo

Clinical Study Site, Salt Lake City

Clinical Study Site, Norfolk

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ilypsa

INDUSTRY